BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/14/2024ACC: 0001562180-24-007692
Officer· Chief Commercial Officer
Since Sep 2021
+18.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
18.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+6.25K
Price / share
—
Trade value
—
% of position
33.8%
11/1/2024
18.49K→24.74K
Total
Net shares
+6.25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2024 | A · Award | +6.25K | — | — | 33.8% | 18.49K | 24.74K |
| Total | +6.25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
+12.50K
Strike price
6.05
Held after
12.50K
Exercisable
—
11/1/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock12.50K shares | 11/1/2024 | A · Award | +12.50K | 6.05 | — | 12.50K |